Antimicrobial peptide interactions with silica bead supported bilayers and E. coli: Buforin II, magainin II, and arenicin

Journal of Peptide Science

Volumn 15, Issue 8, 2009, Pages 511-522

  Davis, Ryan W ^a   Arango, Dulce C ^a   Jones, Howland D T ^a   Van Benthem, Mark H ^a   Haaland, David M ^a   Brozik, Susan M ^a   Sinclair, Michael B ^a  

^a SANDIA NATIONAL LABORATORIES   (United States)

Author keywords

Antimicrobial peptides; Arenicin; Bio materials interfaces; Biomimetic systems; Buforin II; FRET; Magainin II; Mesoporous silica; Multivariate curve resolution; Nanoporous containment; Nanoscale encapsulation; Spectral imaging; Supported bilayers

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ARENICIN; BUFORIN II; MAGAININ 2; PROPIDIUM IODIDE; SILICA BEAD; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ARTICLE; BIOPHYSICS; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; ESCHERICHIA COLI; FLUORESCENCE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SPECIES DIFFERENCE;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ESCHERICHIA COLI; LIPID BILAYERS; LIPOSOMES; MAGAININS; PROTEINS; SILICON DIOXIDE;

EID: 70349649088     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1152     Document Type: Article

References (57)

1. Canon M. A family of wound healers. Nature 1987; 328: 478.
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
3. Giacometti A, Cirioni O, Del Prete MS, Barchiesi F, Paggi AM, Petrelli E, Scalise G. Comparative activities of polycatioinic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. J. Antimicrob. Chemother. 2000; 46: 807-810.
4. Shai Y, Oren Z. From "carpet" mechanism to de-novo designed diasteriomeric cell-selective antimicrobial peptides. Peptides 2001; 22: 1629-1641.
5. Bowman HG. Anitbacterial peptides: basic facts and emerging concepts. J. Intern. Med. 2003; 254: 197-215.
6. Westerhoff HV, Zasloff M, Rosner JL, Hendler RW, De Waal A, Vaz Gomes A, Jongsma PM, Riethorst A, Juretic D. Functional synergism of themagainins PGLa andmagainin-2 in Esherichia coli, tumor cells and liposomes. Eur. J. Biochem. 1995; 228: 257-264.
7. Giacometti A, Cirioni O, Barchiesi F, Fortuna M, Scalise G. In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa. J. Antimicrob. Chemother. 1999; 44: 641-645.
8. Cruz-Chamorro L, Puertollano MA, Puertollano E, de Cienfuegos GA, de Pablo MA. In vitro biological activities of magainin alone or in combination with nisin. Peptides 2006; 27: 1201-1209.
9. Yount NY, Yeaman MR. Multidimensional signatures in antimicrobial peptides. Proc. Natl. Acad. Sci. U.S.A. 2004; 101: 7363-7368.
10. Fjell CD, Hancock REW, Cherkasov A. AMPer: a database and an automated discovery tool for antimicrobial peptides. Bioinformatics 2007; 23: 1148-1155.
11. Guiliani A, Pirri G, Nicoletto SF. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2007; 2: 1-33.
12. Zasloff M.Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial c-DNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 1987; 84: 5449-5453.
13. Duclohier H, Molle G, Spach G. Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers. Biophys. J. 1989; 56: 1017-1021.
14. Matsuzaki K, Murase O, Fujii N, Miyajima K. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry 1995; 34: 6521-6526.
15. Hara T, Kodama H, Kondo M, Wakamatsu K, Takeda A, Tachi T, Matsuzaki K. Effects of peptide dimerization on pore formation: Antiparallel disulfide-dimerized magainin 2 analogue. Biopolymers 2001; 58: 437-446.
16. Park CB, Kim HS, Kim SC. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 1998; 244: 253-257.
17. Takeshima K, Chikushi A, Lee K-K, Yonehara S, Matsuzaki K. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J. Biol. Chem. 2003; 278: 1310-1315.
18. Kobayashi S, Chikushi A, Tougu S, Imura Y, Nishida M, Yano Y, Matsuzaki K. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry 2004; 43: 15610-15616.
19. Uyterhoeven ET, Butler CH, Ko D, Elmore DE. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II. FEBS Lett. 2008; 582: 1715-1718.
20. Yi GS, Park CB, Kim SC, Cheong C. Solution structure of an antimicrobial peptide buforin II. FEBS Lett. 1996; 398: 87-90.
21. Park CB, Yi K-S, Matzusaki K, Kim MS, Kim SC. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell penetrating ability of buforin II. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 8245-8250.
22. Ovchinnikova TV, Aleshina GM, Baladin SV, Krasnosdembskaya AD, Markelov ML, Frovolova EI, Leonova YF, Tagaev AA, Krasnodembsky EG, Kokryakov VN. Purification and primary structure of two isoforms of arenicin, a novel antimicrobial peptide from marine polychaeta Arenicola marina. FEBS Lett. 2004; 577: 209-214.
23. Lee J-U, Kang D-I, Zhu WL, Shin SY, Hahm K-S, Kim Y. Solution structures and biological functions of the antimicrobial peptide, arenicin-1, and its linear derivative. Pept. Sci. 2007; 88: 208-216.
24. Ovchinnikova TV, Shenkarev ZO, Balandin SV, Nadezhin KD, Paramonov AS, Kokryakov VN, Arseniev AS. Molecular insight into the mechanism of antimicrobial action of the β-hairpin peptide arenicin: specific oligomerization in detergent micelles. Biopolymers 2007; 89: 455-464.
25. Andrä J, Jakovkin I, Grötzinger J, Hecht O, Krasnosdembskaya A, Goldmann T, Gutsmann T, Leippe M. Structure and mode of action of the antimicrobial peptide arenicin. Biochem. J. 2008; 410: 113-122.
26. Bradburne JA, Godfry P, Choi JH, Mathis JN. In vivo labeling of Escherichia coli cell envelope proteins with N-hydroxysuccinimide esters of biotin. Appl. Environ. Microbiol. 1993; 59: 663-668.
27. Sinclair MB, Haaland DM, Timlin JA, Jones HDT. Hyperspectral confocal microscope. Appl. Opt. 2006; 45: 6283-6291.
28. Haaland DM, Jones HDT, Sinclair MB, Carson B, Branda C, Poschet JF, Rebeil R, Tian B, Liu P, Brasier AR. Next-generation spectroscopic technologies. Proceedings of SPIE, 6765 SPIE: Boston, MA, 2007.
29. Van Benthem MH, Keenan MR, Haaland DM. Application of equality constraints on variables during alternating least squares procedures. J. Chemometr. 2002; 16: 613-622.
30. Van Benthem MH, Keenan MR. Fast algorithm for the solution of large-scale non-negativity-constrained least squares problems. J. Chemometr. 2004; 18: 441-450.
31. Tauler R, Casassas E, Izquierdoridorsa A. Self-modeling curve resolution in studies of spectrometric titrations of multiequilibria systems by factor-analysis. Anal. Chim. Acta 1991; 248: 447-458.
32. de Juan A, Tauler R. Multivariate curve resolution (MCR) from 2000: progress in concepts and applications. Crit. Rev. Anal. Chem. 2006; 36: 163-176.
33. Kotula PG, Keenan MR, Michael JR. Automated analysis of SEM X-ray spectral images: a powerful new microanalysis tool. Microsc. Microanal. 2003; 9: 1-17.
34. Ohlhausen JAT, Keenan MR, Kotula PG, Peebles DE. Multivariate statistical analysis of time-of-flight secondary ions mass spectrometry images using AXSIA. Appl. Surf. Sci. 2004; 231/232: 230-234.
35. Keenan MR, Kotula PG. Accounting for Poisson noise in the multivariate analysis of ToF-SIMS spectrum images. Surf. Interface Anal. 2004; 36: 203-212.
36. Jones HDT, Haaland DM, Sinclair MB, Melgaard DK, Van Benthem MH, Pedroso MC. Weighting hyperspectral image data for improved multivariate curve resolution results. J. Chemometr. 2008; 22: 482-490.
37. Banning N, Toze S, Mee BJ. Escherichia coli survival in groundwater and effluent measured using a combination of propidium iodide and the green fluorescent protein. J. Appl. Microbiol. 2002; 93: 69-76.
38. Chopra I. The magainins: antimicrobial peptides with potential for topical application. J. Antimicrob. Chemother. 1993; 32: 351-353.
39. Rausch JM, Marks JR, Wimley WC. Rational combinatorial design of pore-forming β-sheet peptides. Proc.Natl. Acad. Sci. U.S.A. 2005; 102: 10511-10515.
40. Yang L, Gordon VD, Mishra A, Som A, Purdy KR, Davis MA, Tew GN, Wong GCL. Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes. J. Am. Chem. Soc. 2007; 129: 12141-12147.
41. Glukhov E, Burrows LL, Deber CM. Membrane interactions of designed cationic antimicrobial peptides: two thresholds. Biopolymers 2008; 89: 360-371.
42. Bechinger B, Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. Biochim. Biophys. Acta 2006; 1758: 1529-1539.
43. Jones G, Vullev VI II. Medium effects on the photophysical properties of terbium(III) complexeswithpyridine-2,6-dicarboxylate. Photochem. Photobiol. Sci. 2002; 1: 925-933.
44. Lakowicz JR. Principles of Fluorescence Spectroscopy, 2nd edn. Kluwer Academic/Plenum Publishers: New York, 1999.
45. Davis RW, Flores A, Barrick TA, Cox JM, Brozik SM, Lopez GP, Brozik JA. Nanoporous microbead supported bilayers: Stability, physical characterization, and incorporation of functional transmembrane proteins. Langmuir 2007; 23: 3864-3872.
46. Burunda T, Huang J, Ramarao GV, Ista LK, Larson RS, Ward TL, Sklar LA, Lopez GP. Biomimetic molecular assemblies on glass and mesoporous silica microbeads for biotechnology. Langmuir 2003; 19: 1654-1663.
47. Leive L. Bacterial Membranes and Walls. M. Dekker: New York, 1973.
48. Cevc G, Marsh D. Phospholipid Bilayers. Wiley and Sons: New York, 1987.
49. Vermaas WFJ, Timlin JA, Jones HDT, Sinclair MB, Nieman LT, Hamad SW, Melgaard DK, Haaland DM. In vivo hyperspectral confocal fluorescence imaging to determine pigment localization and distribution in cyanobacterial cells. Proc. Natl. Acad. Sci. U.S.A. 2008; 105: 4050-4055.
50. Shai Y. Molecular recognition between membrane spanning polypeptides. Trends Biochem. Sci. 1995; 20: 460-464.
51. Arnusch CJ, Branderhorst H, de Kruijff B, Liskamp RM, Breukink E, Pieters RJ. Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides. Biochemistry 2007; 46: 13437-13442.
52. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev.Microbiol. 2005; 3: 238-250.
53. Henriques ST, Melo MN, Castanho MARB. Cell-penetrating peptides and antimicrobial peptides: howdifferent are they?. Biochem. J. 2006; 399: 1-7.
54. Castellana ET, Cremer PS. Solid supported lipid bilayers: from biophysical studies to sensor design. Surf. Sci. Rep. 2006; 61: 429-444.
55. Merzlyakov M, Li E, Gitsov I, Hristova K. Surface-supported bilayers with transmembrane proteins: role of the polymer cushion revisited. Langmuir 2006; 22: 10145-10151.
56. Wagner ML, Tamm LK. Tethered polymer-supported planar lipid bilayers for reconstitution of integral membrane proteins: silane-polyethyleneglycol-lipid as a cushion and covalent linker. Biophys. J. 2000; 79: 1400-1414.
57. Eby DM, Farrington KE, Johnson GR. Synthesis of bioinorganic antimicrobial peptide nanoparticles with potential therapeutic properties. Biomacromolecules 2008; 9: 2487-2494.